Background. High inspiratory oxygen fraction (FI O2 ) may improve tissue oxygenation but also impair pulmonary function. We aimed to assess whether the use of high intraoperative FI O2 increases the risk of major respiratory complications. Methods. We studied patients undergoing non-cardiothoracic surgery involving mechanical ventilation in this hospitalbased registry study. The cases were divided into five groups based on the median FI O2 between intubation and extubation. The primary outcome was a composite of major respiratory complications (re-intubation, respiratory failure, pulmonary oedema, and pneumonia) developed within 7 days after surgery. Secondary outcomes included 30-day mortality. Several predefined covariates were included in a multivariate logistic regression model. Results. The primary analysis included 73 922 cases, of whom 3035 (4.1%) developed a major respiratory complication within 7 days of surgery. For patients in the high-and low-oxygen groups, the median FI O2 was 0.79 [range 0.64-1.00] and 0.31 [0.16-0.34], respectively. Multivariate logistic regression analysis revealed that the median FI O2 was associated in a dosedependent manner with increased risk of respiratory complications (adjusted odds ratio for high vs low FI O2 1.99, 95% confidence interval [1.72-2.31], P-value for trend <0.001). This finding was robust in a series of sensitivity analyses including adjustment for intraoperative oxygenation. High median FI O2 was also associated with 30-day mortality (odds ratio for high vs low FI O2 1.97, 95% confidence interval [1.30-2.99], P-value for trend <0.001).
Postoperative respiratory complications are relatively common, with incidences estimated to range from $3 to 40% studied, [1] [2] [3] and lead to a longer hospital stay, higher costs, and increased mortality. 4 A high intraoperative inspiratory oxygen fraction (FI O2 ) may reduce the incidence of surgical site infection, [5] [6] [7] but the adverse effects remain to be investigated fully. Preoxygenation with 100% oxygen results in atelectasis within a few minutes of induction of anaesthesia. 8 9 Few studies have investigated the effect of intraoperative FI O2 on clinically significant respiratory complications. 10 A recent Cochrane review concluded that evidence is insufficient to support the routine use of a high FI O2 during anaesthesia and surgery, as a significant effect on respiratory insufficiency could not be detected. 11 The number of patients included in the analysis was, however, too small to allow a firm conclusion. Knowledge about potential pulmonary oxygen toxicity also has important implications in critically ill patients, because hundreds of millions of patients receive oxygen therapy every year during mechanical ventilation in the emergency room, intensive care unit (ICU), and operating theatre. 4 In order to increase the arterial oxygen content, clinicians may decide either to increase the FI O2 or to apply a high level of PEEP. An optimal risk-benefit analysis requires knowledge about the consequences of a high inspiratory oxygen concentration for the pulmonary outcome.
In this study, we aimed to investigate the association between intraoperative FI O2 and major respiratory complications, wound dehiscence, ICU admission, and mortality in patients undergoing non-cardiothoracic surgery. Our primary hypothesis was that high intraoperative FI O2 increases the risk of major postoperative respiratory complications independently of predefined markers of co-morbidity and surgical complexity.
Methods

Study design and setting
This was an analysis of data on file on consecutively enrolled adult patients undergoing non-cardiothoracic surgery with tracheal intubation at Massachusetts General Hospital and two affiliated community hospitals between January 2007 and August 2014. Exclusion criteria were as follows: age <18 yr; surgery within 4 weeks before the procedure; or missing information in any of the variables used in the primary regression model (FI O2 or predefined covariates). Approval was obtained from the Partners Institutional Review Board at Massachusetts General Hospital (Boston, MA, USA; protocol no. 2015P000074), and the study was registered at ClinicalTrials.gov (NCT02399878) before any data retrieval.
Data source
Data from two databases, the Anaesthesia Information Management System (AIMS) and the Research Patient Data Registry, were retrieved and combined to provide peri-and postoperative information. All outcomes were identified by incidence of diagnostic codes within the indicated time frame after surgery derived from the World Health Organization International Statistical Classification of Diseases and Related Health Problems, 9th revision (ICD-9) or Current Procedural Terminology (CPT) procedure codes (for a full list, see Supplementary material Table S1 ). Respiratory outcomes have been validated previously based on chart review. 4 12 
Outcome measures
The primary outcome was a composite of major respiratory complications (re-intubation, respiratory failure, pulmonary oedema, and pneumonia) developed within 7 days of surgery. Secondary outcomes were wound dehiscence within 21 days, admission to the ICU within 7 days, and mortality within 7 and 30 days of surgery. Exploratory outcomes were stroke within 30 days and myocardial infarction or positive troponin test within 30 days after surgery.
Exposure and covariate data
The exposure variable was the median intraoperative FI O2 between intubation and extubation. The FI O2 is prospectively recorded every minute in AIMS. Information on the following potential confounders was collected and included in the logistic regression analysis: sex, age, BMI, ASA physical status classification, Score for Prediction Of Postoperative Respiratory Complications (SPORC), 12 chronic obstructive pulmonary disease (COPD), Charlson comorbidity index (CCI), 13 duration of anaesthesia, opioid, 14 15 volatile anaesthetics, 15 16 
Statistical analysis
Continuous and ordinal variables are described as the median (interquartile range [IQR]/(range)) and categorical variables as number (percentage), if not otherwise specified. Based on their ranking and in order to adjust for non-linear relationship, continuous variables, including median FI O2 , were divided into
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quintiles and ordinal variables were divided into clinically relevant categories. 8 15 The associations between FI O2 and outcomes were examined across all five groups of FI O2 using the significance of the Pearson partial correlation coefficient as the Pvalue for trend in an a priori-defined logistic regression model including the following predefined covariates: sex, age, BMI, ASA, COPD, CCI, SPORC, duration of anaesthesia, opioids, volatile anaesthetics, fluid administration, blood transfusion, PEEP, tidal volume per predicted body weight, NMBA-ED95, emergency surgery, admission type, PSS morbidity score, and surgical service. When analysing the risk of mortality, PSS morbidity score was replaced by PSS score for mortality.
Sensitivity analyses
Several sensitivity analyses were conducted to evaluate the association between FI O2 and respiratory complications further; these analyses included evaluation of the association between the median FI O2 and the risk of major respiratory complications within subgroups of patients stratified for estimated propensity score for assignment to the highest FI O2 quintile. The propensity score was calculated using a logistic regression model, with treatment status (receiving a high median FI O2 ) as the dependent variable. In order to address the effects of the duration of exposure to high inspiratory concentration of oxygen, we assessed the association between cumulative minutes of receiving a high median FI O2 and the primary outcome (see the Supplementary material).
Exploratory analyses
Additional exploratory analyses were performed.
One could argue that the association between FI O2 and major postoperative respiratory complications might be an epiphenomenon of a pre-existing impairment of oxygenation despite extensive confounder control. In an exploratory analysis, we included the Sp O2 =FI O2 measured 5 min after intubation in the regression model. We also repeated the primary analysis in the subgroup of patients with pre-existing COPD. Furthermore, we added FI O2 variables representing distinct parts of the surgical procedure to our multivariate adjusted analysis. We also controlled for the last TOF count obtained before extubation in an additional exploratory analysis.
In order to evaluate further whether the association between median FI O2 and risk of respiratory complications might be an epiphenomenon of impaired intraoperative oxygenation, we reran the primary analysis including median intraoperative partial pressure of oxygen (Pa O2 )/median intraoperative FI O2 in the list of covariates in patients who received an intraoperative arterial blood gas analysis.
Moreover, to investigate the impact of variation by individual providers on respiratory complication rate, we used a mixed-effects logistic regression, with individual provider as a random effect variable.
To evaluate the effect of FI O2 on non-pulmonary organs, the associations between FI O2 and risk of myocardial infarct as well as stroke were evaluated using the same confounder control as for the primary analysis.
In order to control for a possible bias related to missing data, we also conducted multiple imputation by chained equations. 8 Missing variables were imputed using all variables included in the primary analysis except inclusion and exclusion criteria.
The analyses were performed using SPSS version 20 (IBM) and SAS version 9.3. Results are presented as odds ratios (ORs) with 95% confidence intervals (CIs), and a two-tailed P-value of <0.05 is considered to be statistically significant.
Full details of methods are available in the Supplementary material.
Results
A total of 138 996 surgical cases between 2007 and 2014 were assessed for eligibility (Fig. 1 ). After exclusion, based on the predefined criteria, the cohort for the primary analysis consisted of 73 922 cases, and was divided into quintiles according to median intraoperative FI O2 (Table 1 ). The median FI O2 in the group receiving the lowest oxygen concentrations (low FI O2 ) was 0.31 [range 0.16-0.34] and in the group receiving the highest oxygen concentrations (high FI O2 ) 0.79 [range 0.64-1.00]. All groups were similar in terms of patient characteristics and other ventilatory settings. The composite outcome of major respiratory complications within 7 days of surgery occurred in 3035 (4.1%) cases, of whom 780 (1.1%) had pneumonia, 1979 (2.7%) had pulmonary oedema, 949 (1.3%) had respiratory failure, and 243 (0.3%) were re-intubated ( Table 2 ). Wound dehiscence within 21 days was diagnosed in 311 (0.4%) cases, and 2293 (3.1%) cases were admitted to the ICU within the first 7 postoperative days. Fifty-six (0.1%) and 394 (0.5%) patients died within 7 and 30 days after surgery, respectively.
Primary analysis
Logistic regression revealed a higher risk of major respiratory complications with increasing intraoperative median FI O2 in a dose-dependent fashion (adjusted OR for high FI O2 vs low FI O2 1.99, 95% CI [1.72-2.31], P for trend <0.001; Table 3 ).
Secondary analyses
We found a higher risk of mortality within 7 and 30 days after surgery with higher median FI O2 in a dose-dependent fashion (7- Table 3 ). There was no significant dose-dependent association between median FI O2 and risk of wound dehiscence or admission to the ICU within 7 days after surgery (Table 3) .
Sensitivity analyses
The mean value of the median FI O2 in patients with major respiratory complications was significantly higher than in patients without complications [mean (SD) 0.56 (0.20) and 0.51 (0.17), respectively, P<0.001].
The association between median FI O2 and risk of major respiratory complications was also statistically significant when adjusting only for sex, age, ASA status, and duration of anaesthesia (Supplementary material Fig. S1 ).
The results of the primary analysis remained robust when repeated within subgroups of cases stratified based on their estimated propensity score for receiving high FI O2 (Fig. 2) .
The result of the primary analysis was unchanged when repeated in only the 42 875 cases with anaesthesia of longer duration (>120 min), with an adjusted OR ¼ 2.03 (95% CI [1.70-2.43], P for trend <0.001) for the composite respiratory outcome, high FI O2 vs low FI O2 .
The risk of major respiratory complications did increase with increased exposure to high FI O2 (adjusted OR for median After excluding patients who died within 7 days of surgery, the median FI O2 was still associated with the risk of a major respiratory complications (adjusted OR high FI O2 vs low FI O2 1.98, 95% CI [1.70-2.30], P for trend <0.001). Also, assuming that patients who died within 7 days of surgery had a major respiratory complication did not change the association.
Exploratory analyses
The primary analysis was repeated after adding the Sp O2 =FI O2 ratio obtained 5 min after intubation as a covariate to the model. The results were similar to those found in the primary analysis (adjusted OR of respiratory complications high FI O2 vs low FI O2 2.10, 95% CI [1.79-2.46], P for trend <0.001; Supplementary material Fig. S3 ). The results also remained stable when controlling for high risk of obstructive sleep apnoea (SPOSA >7; adjusted OR of respiratory complications high FI O2 vs low FI O2 1.99, 95% CI [1.72-2.31], P for trend <0.001). The incidence of major respiratory complications in patients with COPD was 6.6%, and the effect of intraoperative FI O2 on the risk of a major respiratory complication was similar to that of the total cohort (Supplementary material Fig. S4 ).
Data on intraoperative Pa O2 were available in 5837 of the included patients. Approximately 61% (n¼3533) of the patients had a median Pa O2 >20 kPa, and 33% in the group receiving the highest oxygen concentrations had a median Pa O2 >40 kPa. Fig. S7 ).
The association of median FI O2 retained its effect size even after accounting for additional FI O2 variables measured during different time intervals of the procedure (Supplementary material Table S2 ).
The results of the primary analysis also remained robust when repeated across decile groups based on the median FI O2 , and no clear threshold for a safe FI O2 with regard to risk of respiratory complications could be identified (Supplementary material Fig. S8 ).
The increase in risk of respiratory complications associated with high FI O2 remained significant when including individual anaesthesia provider as a random effect variable to the model in addition to all the other fixed effect variables from the primary analysis (adjusted OR for high vs low FI O2 1.46, 95% CI [1.30-1.64], P for trend <0.001).
The association between median FI O2 and postoperative respiratory complications remained stable after including the last 
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Acute myocardial infarction was diagnosed in 172 (0.2%) patients, and 279 (0.4%) patients had a positive troponin test ( Table 2 ). The risk of cardiac injury was not significantly associated with high oxygen in a dose-dependent fashion (Table 3) . Finally, 341 (0.5%) patients had a stroke after surgery, but the risk was not associated with FI O2 (Tables 2 and 3) .
Discussion
In an analysis of administrative data on file from a large cohort of surgical patients undergoing intraoperative mechanical ventilation for non-cardiothoracic surgery, we found that high median intraoperative FI O2 was significantly associated with a composite outcome of major postoperative respiratory complications. High FI O2 was also associated with increased risk of 30-day mortality. Our analyses controlled for a predefined set of confounding variables and were robust across a series of sensitivity analyses including markers of surgical complexity, comorbidities, pulmonary function, intraoperative oxygenation, and duration of exposure.
The analyses in this study were made on basis of a large data set that reflects routine clinical practice. Data were retrieved from accurate and prospective recording of intraoperative management and postoperative complications. Before initiating data analysis, we finalized the protocol, including definitions of risk factors and outcomes, and registered the study at ClinicalTrials.gov. The observational design allowed us to collect a large number of events, which provided the analysis with sufficient power to detect differences in relatively infrequent complications. A specific strength relates to the availability of arterial blood gas analyses, which allowed us to discriminate between supranormal arterial oxygen tension (hyperoxygenation) and adequate treatment of hypoxic respiratory failure. However, some important limitations must be mentioned. First, we adjusted for a large number of different risk factors and performed several sensitivity analyses, including propensity scoring, in order to reduce the risk of confounding. Optimally, our results should be confirmed in a future randomized controlled trial. However, because of the low event rate of clinically meaningful respiratory complications in patients undergoing surgery, and multiple risk factors (co-morbidities and procedure-related factors), a randomized controlled trial would need to be conducted in several thousand patients.
Residual and unmeasurable confounding cannot be eliminated. For example, we are not able to know why the anaesthesia provider decided to use the oxygen fraction recorded. Our oxygenation data clearly exclude the possibility that the association between FI O2 and respiratory complications is attributable to baseline hypoxia. Rather, many anaesthetists apparently hyperoxygenate their patients, and a likely explanation for our finding is that the value of FI O2 was selected based on personal preference of the anaesthesia provider. Our institution has no standard operating procedure for intraoperative FI O2 value. One could argue that the anaesthesia provider is a confounding variable of the association between FI O2 and respiratory complications. Therefore, we accounted for clustering of patients by provider. We found that the association between the FI O2 and the risk of respiratory complications remained unchanged from the primary analysis. Data on postoperative management that could have influenced the occurrence of respiratory outcomes were not available. However, it is unlikely that those are directly related to intraoperative FI O2 values and their association with respiratory complication rates. The median FI O2 throughout the procedure might not adequately represent the burden of a high oxygen concentration. Therefore, in additional exploratory analyses we included the FI O2 measured during distinct parts of the surgical procedure to evaluate whether the observed effect of median FI O2 in occurrence of respiratory complications was affected. We observed that the FI O2 measured immediately after intubation and before extubation, or the range of FI O2 used during the procedure, did not explain any variance of postoperative respiratory complications. In addition, adding these variables to the primary regression model did not change the association between median FI O2 and respiratory complications (see Supplementary material Table S2 ). We did not include information on FI O2 values before intubation because the accuracy of this variable will depend on multiple factors.
Residual neuromuscular block is associated with respiratory complications. In our study, we controlled for neuromuscular blocking agent dose and neostigmine dose and for the last TOF count documented before extubation as a potential indicator of postoperative residual neuromuscular block. Furthermore, we extended the analysis and included additional confounders (epidural analgesia, driving pressure, duration of hypotension, and ventilation mode) in an exploratory analysis. This did not change the primary results (Supplementary material, Results section). The partial correlation coefficients between FI O2 and respiratory complications were small, but we did not expect to see a close correlation between FI O2 and respiratory complication rate because only a fraction of the occurrence of postoperative respiratory complications can be explained by oxygen toxicity.
There is substantial controversy among clinicians on the appropriate FI O2 settings to be used during intraoperative mechanical ventilation. This is because proposed advantageous effects of hyperoxia, such as reduction of surgical wound infection [5] [6] [7] and increased time for desaturation, could be offset by deleterious effects, such as the increase in atelectasis, 19 oxidative stress to the lungs, 20 and exacerbation of cancer effects. 21 Our results
show that anaesthetists provide values of FI O2 that result in intraoperative oxygen saturations above the average observed in normal humans at rest. Yet, despite this evidence and those potentially major effects, only few studies have investigated the association between perioperative oxygen concentration and postoperative respiratory complications. [22] [23] [24] We found a significant association between intraoperative FI O2 and major postoperative complications, which is in contrast to previously conducted, smaller studies, [22] [23] one larger controlled trial in 1386 patients, 24 and two systematic reviews, 7 11 which failed to
show an effect of FI O2 despite the observation of specific physiological effects in both high and low FI O2 groups. Several mechanisms might contribute to an oxygen-related lung injury. High alveolar oxygen concentration leads to faster collapse of small lung units as a result of absorption of oxygenrich gas into the blood from closed off alveoli or alveoli with very low ventilation/perfusion ratios. 25 The resulting atelectasis leads to intrapulmonary shunt and impaired oxygenation. 25 The amount of atelectasis depends on the oxygen concentration and the duration of high oxygen administration. 25 26 Atelectasis is likely to be a focus of infection and may contribute to additional pulmonary complications. 26 Severe atelectasis may even be a contributing early mechanism of ventilator-associated lung injury, as animal studies have shown that non-lobar atelectasis also leads to inflammation and alveolar injury in the nonatelectatic areas. 27 28 Another plausible mechanism behind the oxygen-related lung injury is hyperoxia-induced oxidative stress. 20 Hyperoxia and inflammation accelerate the formation of reactive oxygen species and cellular damage. 20 The innate antioxidant system normally protects against excessive radicals but becomes overwhelmed in the event of prolonged hyperoxia. 20 The oxygenrelated injury may be of particular relevance to patients with underlying lung pathology.
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The oxygen-related injury also applies to non-pulmonary organs. High-flow oxygen to patients with myocardial infarction and normoxia leads to elevated creatinine kinase and larger infarct size, 30 probably by increased coronary vascular resistance, reduced coronary blood flow and cardiac index, and generation of reactive oxygen species. 31 32 Hyperoxia may thus be hypothesized to increase the risk of myocardial infarction after surgery. 33 Finally, in a study of patients admitted to the ICU after resuscitation from cardiac arrest, arterial hyperoxia was independently associated with increased inhospital mortality. 34 However, we found no significant association between high FI O2 and cardiac or cerebral morbidity. This may be a result of lack of power to detect these outcomes in our study. We did find a significant dose-response association between administrated oxygen and 30-day mortality. Increased longterm mortality has also been reported in patients randomized to a high FI O2 during abdominal surgery. 21 It is possible that the increased risk of mortality associated with increased FI O2 in our study is related to an impairment of cardiac function. Moreover, it is possible that our finding of increased occurrence of pulmonary oedema with hyperoxia may be explained in part by cardiogenic pulmonary oedema secondary to myocardial injury. 35 A significant association between hyperoxia and increased morbidity was also found in a recently published trial, where patients admitted to the ICU were randomly allocated to standard or conservative oxygen therapy. 36 We did not find any significant association between wound dehiscence and FI O2 . However, the incidence was significantly lower than reported in prospective trials. 24 Hyperoxia increases the tolerance to apnoea and hypopnea and is frequently used by anaesthetists to prevent intraoperative hypoxia in critical situations, such as before induction and during emergence from anaesthesia. 19 In a similar way, in critically ill patients in the operating room or the ICU, Pa O2 may be kept well above the normal range in order to prevent hypoxia and because this is considered as to be without associated risks. In our subgroup of patients who had an arterial blood gas analysis done, >60% of the patients had a median Pa O2 >20 kPa. and respiratory complications was unchanged (see Supplementary material). This observation, together with that of a dose-response relationship between median FI O2 and respiratory complications, supports the hypothesis that increases in FI O2 in our studied patients were not merely targeting the maintenance of a specific value of normal blood oxygenation. Instead, they produced supraphysiological conditions, which could have resulted in the observed complications through the mechanisms discussed above. The contribution of supraphysiological oxygenation could have been either as an independent factor or as a factor synergistic with that of lung injury from other causes (the 'two-hit' hypothesis) in producing further deterioration.
Clinical and scientific implications
Our data suggest that oxygen therapy should be titrated to normal values unless there is clear evidence of benefits, because supraphysiological oxygen values are found in many patients.
In this analysis of administrative data on file, our results showed a rather consistent pattern of a two-fold increase in the risk of respiratory complications for an absolute increase in FI O2 from the lowest quintile of 0.31 to the highest quintile of 0.80. The same pattern was observed for 30-day mortality.
We hope that our data will inform the design of prospective studies on the effects of FI O2 in the perioperative period. Of note, direct clinical conclusions that change the clinical treatment of our patients may only be drawn with caution. In fact, oxygenation data obtained during surgery were available in only a fraction of our patients. Based on our data, the role of perioperative oxygenation should be investigated further in large observational studies and optimally in a well-designed and conducted randomized controlled trial. However, because of relatively low incidences of these outcomes among the general surgical population, we recommend that the focus should be on a population of increased susceptibility to postoperative complications or patients admitted to the ICU, who are intubated and mechanically ventilated in the absence of hypoxic respiratory failure. In this analysis of administrative data on file, a high intraoperative FI O2 was associated in a dose-dependent manner with the postoperative occurrence of major respiratory complication within 7 days, and with 30-day mortality independently of predefined risk factors. This finding was robust in a series of sensitivity analyses including intraoperative oxygenation. 
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